A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Genes implicated in hereditary breast cancer syndromes.
Estrogens, BRCA1, and breast cancer.
Mutation of breast cancer susceptibility gene in ovarian cancer and its clinical significance.
Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
Evidence for a transcriptional activation function of BRCA1 C-terminal region.
The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
BRCA1 mutations in a population-based sample of young women with breast cancer.
Rapid detection of BRCA1 mutations by the protein truncation test.
BRCA1 mutations in primary breast and ovarian carcinomas.
Implication of BRCA1 gene in breast cancer
Clinical and pathological characteristics and follow-up of patients with breast cancer and BRCA1/BRCA2 mutations
Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis
Genetic interactions between tumor suppressors BRCA1 and p53 in apoptosis, cell cycle and tumorigenesis
BRCA1 and prostate cancer.